Q4 2025 Holdings
Filed 2026-02-17 | 11 holdings | $286.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Nuvation Bio(NUVB) | Common Stock Class A | 67080N101 | $72.4M | 8,081,089 | 25.3% |
| BridgeBio Oncology Therapeutics Inc.(BBOT) | Common Stock | 107924102 | $41.2M | 3,289,661 | 14.4% |
| Beta Bionics Inc.(BBNX) | Common Stock | 08659B102 | $40.1M | 1,316,183 | 14.0% |
| Bicara Therapeutics Inc.(BCAX) | Common Stock | 055477103 | $37.1M | 2,204,650 | 12.9% |
| Kestra Med Technologies Ltd(KMTS) | Common Stock | G52441105 | $36.4M | 1,373,591 | 12.7% |
| Upstream Bio Inc.(UPB) | Common Stock | 91678A107 | $36.0M | 1,326,293 | 12.6% |
| enGene Holdings Inc.(ENGN) | Common Stock | 29286M105 | $7.9M | 876,357 | 2.8% |
| Alumis Inc.(ALMS) | Common Stock | 022307102 | $6.4M | 653,223 | 2.2% |
| Sana Biotechnology, Inc.(SANA) | Common Stock | 799566104 | $3.4M | 843,750 | 1.2% |
| ImageneBio, Inc.(IMA) | Common Stock | 45175G207 | $3.1M | 455,361 | 1.1% |
| Replimune Group(REPL) | Common Stock | 76029N106 | $2.4M | 248,672 | 0.8% |